Taken together, these results indicated that AEBP1 might exert oncogenic effects in oral cancer progression, and AEBP1 silencing may suppress the progress of oral cancer by inhibiting proliferation, migration, and invasion. The gene discussed is AEBP1; the disease is lip and oral cavity carcinoma.